As of the latest SEC filings, EyePoint, Inc. (EYPT) is held by 161 institutional funds. The largest fund shareholder is Federated Hermes Kaufmann Fund (KAUAX), holding an estimated $36,583,628.40 in market value, representing 0.78% of its portfolio.
Funds holding EyePoint, Inc. (EYPT)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- EYPT
- CIK:
- 0001314102
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
KAUAX
Federated Hermes Kaufmann Fund
|
MF | Federated Hermes | 0.78% | $36,583,628.40 | 2,771,487 | Apr 30, 2026 | Jun 23, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $33,525,085.40 | 2,600,860 | Mar 31, 2026 | May 28, 2026 |
|
FKASX
Federated Hermes Kaufmann Small Cap Fund
|
MF | Federated Hermes | 0.91% | $26,162,400.00 | 1,982,000 | Apr 30, 2026 | Jun 23, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.03% | $24,353,837.51 | 1,889,359 | Mar 31, 2026 | May 28, 2026 |
|
FSSAX
Franklin Small Cap Growth Fund
|
MF | Franklin Templeton | 0.81% | $19,889,113.20 | 1,506,751 | Apr 30, 2026 | Jun 24, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 1.01% | $16,055,564.87 | 1,245,583 | Mar 31, 2026 | May 29, 2026 |
|
FBTDX
Franklin Biotechnology Discovery Fund
|
MF | Franklin Templeton | 1.43% | $14,830,134.00 | 1,123,495 | Apr 30, 2026 | Jun 24, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 1.27% | $14,467,387.97 | 1,122,373 | Mar 31, 2026 | May 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $11,222,614.05 | 870,645 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.03% | $10,126,380.00 | 767,150 | Apr 30, 2026 | Jun 26, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.07% | $8,579,609.78 | 665,602 | Mar 31, 2026 | May 28, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 1.42% | $7,940,304.45 | 616,005 | Mar 31, 2026 | May 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $7,315,408.20 | 416,595 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.03% | $6,587,686.68 | 375,153 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.04% | $6,574,095.24 | 374,379 | Feb 28, 2026 | Apr 28, 2026 |
|
QASCX
Federated Hermes MDT Small Cap Core Fund
|
MF | Federated Hermes | 0.28% | $5,277,294.00 | 399,795 | Apr 30, 2026 | Jun 23, 2026 |
|
XPH
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
|
ETF | State Street (SPDR) | 1.66% | $5,100,276.53 | 395,677 | Mar 31, 2026 | May 28, 2026 |
|
PINK
Simplify Health Care ETF
|
ETF | Independent / Boutique | 1.52% | $3,552,187.53 | 275,577 | Mar 31, 2026 | May 27, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.02% | $3,277,626.68 | 186,653 | Feb 28, 2026 | Apr 28, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.05% | $3,274,553.68 | 186,478 | Feb 27, 2026 | Apr 24, 2026 |
|
QASGX
Federated Hermes MDT Small Cap Growth Fund
|
MF | Federated Hermes | 0.39% | $2,927,007.60 | 221,743 | Apr 30, 2026 | Jun 23, 2026 |
|
IHE
iShares U.S. Pharmaceuticals ETF
|
ETF | BlackRock / iShares | 0.28% | $2,803,652.34 | 217,506 | Mar 31, 2026 | May 22, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $2,655,001.76 | 151,196 | Feb 28, 2026 | Apr 24, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.21% | $2,518,306.41 | 195,369 | Mar 31, 2026 | May 28, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.03% | $2,248,844.40 | 170,367 | Apr 30, 2026 | Jun 25, 2026 |
Advertisement (320x50)